NasdaqCM - Delayed Quote USD

Singular Genomics Systems, Inc. (OMIC)

Compare
14.00 +0.04 (+0.29%)
At close: October 25 at 4:00 PM EDT
14.00 0.00 (0.00%)
After hours: October 25 at 4:35 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Andrew Spaventa Founder, CEO, President & Chairperson of the Board 853.56k -- 1985
Dr. David L. Barker Ph.D. Founder, Member of Scientific Advisory Board & Independent Director 66.25k -- 1942
Dr. Eli N. Glezer Ph.D. Founder, Chief Scientific Officer & Chair of Scientific Advisory Board 548.32k -- 1969
Mr. Dalen Meeter Chief Financial Officer 545.67k -- 1978
Dr. Jyotsna Ghai Ph.D. Chief Operating Officer -- -- 1959
Mr. Eric Stier Senior VP, General Counsel & Secretary -- -- 1976
Mr. Jeff Bullard Head of Sales -- -- --
Mr. Vincent Brancaccio Head of Human Resources -- -- 1983
Mr. Jorge Velarde Jr., MBA Chief Business Officer -- -- 1967

Singular Genomics Systems, Inc.

3010 Science Park Road
San Diego, CA 92121
United States
858 333 7830 https://www.singulargenomics.com
Sector:?
Healthcare
Full Time Employees:?
255

Description

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

Corporate Governance

Singular Genomics Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 13, 2024 at 8:05 PM UTC

Singular Genomics Systems, Inc. Earnings Date

Recent Events

September 19, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 13, 2024 at 8:30 PM UTC

Q2 2024 Earnings Call

August 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 7, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 15, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 27, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 18, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

Related Tickers